SCHEDULE 13G

Statement of Beneficial Ownership

Acumen Pharmaceuticals, Inc. Filed 2026-04-07 Acc 0001140361-26-013660

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-04-07 SCHEDULE 13G Statement of Beneficial Ownership
2026-04-01 EFFECT Notice of Effectiveness
2026-04-01 424B3 Prospectus

Link to a passage

External

SEC EDGAR (opens in new tab)